Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Long-Term Investments: 2010-2014

  • Avadel Pharmaceuticals' Long-Term Investments fell 18.83% to $125,000 in Q4 2014 from the same period last year, while for Dec 2014 it was $125,000, marking a year-over-year decrease of 18.83%. This contributed to the annual value of $125,000 for FY2014, which is 18.83% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Long-Term Investments stood at $125,000 for Q4 2014, which was down 18.83% from $154,000 recorded in Q4 2013.
  • Over the past 5 years, Avadel Pharmaceuticals' Long-Term Investments peaked at $186,000 during Q4 2010, and registered a low of $125,000 during Q4 2014.
  • Over the past 3 years, Avadel Pharmaceuticals' median Long-Term Investments value was $154,000 (recorded in 2013), while the average stood at $154,000.
  • Its Long-Term Investments has fluctuated over the past 5 years, first rose by 11.59% in 2012, then decreased by 18.83% in 2014.
  • Avadel Pharmaceuticals' Long-Term Investments (Quarterly) stood at $186,000 in 2010, then decreased by 11.83% to $164,000 in 2011, then grew by 11.59% to $183,000 in 2012, then decreased by 15.85% to $154,000 in 2013, then fell by 18.83% to $125,000 in 2014.
  • Its Long-Term Investments was $125,000 in Q4 2014, compared to $154,000 in Q4 2013 and $183,000 in Q4 2012.